Palantir Technologies shares extended their losing streak to a seventh consecutive trading session on June 25, pushing the AI software stock toward a fresh 52-week low.
PLTR stock fell about 5% to roughly $107 during the session, bringing its decline since the previous Tuesday to more than 20%. The shares were also down approximately 31% in June and nearly 48% from their November 2025 record high of $207.18.
The retreat comes despite strong recent revenue growth and upgraded full-year guidance. Investors appear increasingly focused on Palantir’s elevated valuation, weakness across the broader software sector, rising interest-rate expectations and political risks surrounding some European government contracts.
Why Palantir Stock Is Falling
There does not appear to be one single event behind the seven-session decline. Instead, several pressures have converged.
The first is a wider selloff in high-multiple software and AI stocks. The technology sector has come under pressure as investors question whether some companies’ valuations moved too far ahead of near-term earnings and cash flow.
The iShares Expanded Tech-Software Sector ETF was down approximately 19% in 2026 as of June 25, showing that Palantir’s weakness is part of a broader industry trend. However, PLTR has underperformed even that benchmark, falling about 36% since the beginning of the year.
Rising interest-rate expectations have added to the pressure. Higher bond yields tend to reduce the present value investors assign to future earnings, creating a particular challenge for growth stocks trading at high earnings multiples.
Palantir’s valuation remains demanding even after the decline. Recent market data placed its trailing price-to-earnings ratio above 130, while estimates of its forward multiple remained close to or above 90 depending on the earnings assumptions used.
Such a valuation requires continued exceptional growth. Any sign of slower commercial demand, contract uncertainty or industry disruption can therefore produce an outsized stock-price reaction.
Technical Damage Adds to Selling Pressure
The seven-day decline has also weakened Palantir’s technical market position.
The stock fell below support near $127, a level that had held since February, and moved beneath both its 50-day and 200-day moving averages. These indicators are closely followed by technical traders and quantitative investment strategies.
Breaking major support levels can trigger additional selling as stop-loss orders are activated and momentum-based funds reduce exposure.
PLTR stock also approached a fresh 12-month low during the June 25 session. The decline marked its worst monthly performance since February 2021, when the shares fell approximately 32%.
Technical weakness does not determine the company’s long-term value, but it can amplify short-term volatility. Investors using an online broker or stock trading platform should recognize that a falling share price can create its own momentum even when the underlying business remains profitable and continues growing.
European Contract Risks Weigh on Sentiment
Political and procurement developments in Europe have added another layer of uncertainty.
France recently announced plans to replace Palantir’s software at its domestic intelligence agency with technology from French company ChapsVision. The transition could take several years, and the direct financial impact may be limited, but the decision is symbolically important because it reflects Europe’s increasing focus on digital sovereignty and local technology providers.
In the United Kingdom, lawmakers have criticized the government’s reliance on Palantir and described its role in the public sector as a potential point of weakness. The concerns include vendor dependence, data governance and the company’s broader political associations.
Palantir’s work with the National Health Service has also faced scrutiny. A recent report said NHS England acknowledged that performance claims associated with its Federated Data Platform did not conclusively establish that Palantir’s software caused the reported improvements.
Separately, London Mayor Sadiq Khan blocked a proposed £50 million Metropolitan Police contract because of concerns about the procurement process. Palantir threatened legal action, although the existing pilot program subsequently received a 12-month extension while a new competitive process is conducted.
None of these developments alone represents an existential threat. Together, however, they create uncertainty around Palantir’s European government business and reinforce concerns about dependence on politically sensitive contracts.
Palantir’s Business Growth Remains Strong
The sharp PLTR stock selloff contrasts with the company’s recent financial performance.
Palantir reported that first-quarter 2026 revenue increased 85% year over year, while U.S. revenue rose 104% to $1.282 billion. The company also raised its full-year revenue forecast to approximately $7.65 billion to $7.66 billion.
U.S. government demand remains a major growth engine. Palantir’s Maven AI platform is expected to become an official Pentagon program of record, potentially giving the company a more durable role in military command, intelligence and battlefield-data systems.
The company has also continued winning significant contracts. Its recent agreements include an expanded Army Vantage partnership valued at $618.9 million, according to Palantir’s corporate newsroom.
These results support the bullish view that Palantir is becoming one of the most strategically important enterprise AI software providers.
The challenge is not whether Palantir is growing. It is whether growth can remain high enough for long enough to justify a valuation still well above most mature software companies.
Commercial Growth Is a Key Investor Concern
Although Palantir’s U.S. government business has been strong, investors are also watching its commercial segment closely.
Palantir’s Artificial Intelligence Platform, known as AIP, is designed to help businesses connect large language models with internal data and operational workflows. The platform has attracted attention because it focuses on deploying AI within real-world organizations rather than offering a general-purpose consumer chatbot.
However, competition is intensifying. OpenAI, Anthropic, Microsoft, Google and enterprise-software companies are all developing tools that allow customers to build AI agents, analyze proprietary data and automate processes.
Some investors fear that increasingly capable foundation-model providers could compete directly with software companies such as Palantir. Others argue that Palantir’s advantage lies in implementation, security and its ability to integrate complex data environments.
The next earnings report will need to show that commercial growth remains strong and that customers are expanding their use of AIP after initial deployments.
Is Palantir’s Valuation Still Too High?
Valuation is likely the central issue in the Palantir stock outlook.
Even after losing nearly half its value from the November peak, the company trades at a multiple that assumes years of rapid growth and improving profitability.
A high valuation is not automatically unjustified. Companies that build durable platforms and maintain strong revenue growth can support premium multiples for long periods.
The risk arises when expectations leave little room for disappointment. Slower contract growth, weaker margins, higher interest rates or greater competition could force investors to apply a lower multiple even if Palantir continues expanding.
For long-term investing, buyers must therefore consider both business quality and the price paid for that growth.
A company can remain operationally successful while its stock underperforms if the previous valuation was too optimistic.
What Investors Should Watch Next
The next major catalyst will be Palantir’s second-quarter earnings report.
Investors should focus on U.S. commercial growth, government-contract momentum, operating margins and any revision to the company’s 2026 revenue guidance.
European contract developments will also matter. Further losses in France or the United Kingdom could reinforce concerns about regional political resistance, while new contract wins could reduce those fears.
Technical levels may influence near-term trading. The stock’s ability to stabilize around its 52-week low could determine whether selling pressure begins to ease or accelerates.
Interest rates and software-sector performance will remain important as well. A decline in bond yields or renewed enthusiasm for AI software stocks could support a recovery, while continued rotation away from high-multiple growth companies would create another headwind.
Palantir’s underlying growth remains strong, but the seven-session decline shows that excellent business results do not eliminate valuation and market-timing risk.
FAQ
Why is Palantir stock falling?
Palantir shares are under pressure because of high valuation concerns, a broader selloff in software stocks, rising interest-rate expectations, technical weakness and uncertainty surrounding some European government contracts.
How much has PLTR stock fallen?
Palantir fell for seven consecutive sessions through June 25, declining more than 20% during that period. The stock was approximately 48% below its November 2025 record high.
Is Palantir still growing?
Yes. Palantir reported 85% year-over-year revenue growth in the first quarter of 2026 and raised its full-year revenue forecast to approximately $7.65 billion to $7.66 billion.
What are the main risks for PLTR stock?
The main risks include a high valuation, slower commercial growth, competition from other AI platforms, political pressure on government contracts and continued weakness across high-multiple software stocks.
Is Palantir one of the best AI stocks to buy now?
Palantir has strong AI software growth and major government relationships, but its valuation and volatility remain substantial. Investors should compare its growth assumptions with its market price and consider PLTR within a diversified investment strategy.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Always conduct your own research before making any investment decisions.
